Life Sciences / Growth Hormone Market Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players- Eli Lilly And Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc
Growth Hormone Market Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players- Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc
Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global Growth Hormone Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 7.6% during the review period (2022 to 2027).
Global Growth Hormone Market Overview
Human growth hormone (HGH), also known as somatotropin, is a peptide hormone responsible for growth stimulation, cell imitation, and cell regeneration in humans and is hence important for human development. Growth hormone (GH) deficiency in humans is caused when the hypophysis gland does not synthesize enough attention of hGH. This lack in humans is treated by administering recombinant human growth hormone by subcutaneous injection. Various genetic disorders, including Prader-Willi syndrome and Turner syndrome, may also cause growth hormone deficiency in humans, leading to delayed puberty and shorter-than-average height. In humans, the growth hormone deficiency is caused when the pituitary gland does not synthesize enough concentration of human growth hormones. This lack is treated by administering recombinant human growth hormones by subcutaneous injection. Various genetic disorders such as Prader-Willi syndrome and Turner syndrome may also cause development hormone deficiency, leading to delayed puberty and shorter-than-average height.
Human growth hormone helps promote renewal, reproduction, and growth. Bigger use of growth hormone and growth hormone awareness, which helps in the management of hormonal disparity disorders, enhances the market growth.
Who are the Prime Players in Growth Hormone Market?
The Global Growth Hormone Market includes identification and analysis of the various market participants competing in the global market. Prime competitors include Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc. and Sandoz,, TEVA PHARMACEUTICAL INDUSTRIES., Anhui Anke Biotechnology (Group) Co.,
Industry News and Updates:
Jan 20, 2022: Novo Nordisk launches anti-diabetes pill semaglutide in India
Novo Nordisk, the Danish drug maker on has announced the launch of oral semaglutide in India for treatment of type 2 diabetes.The oral semaglutide will cost Rs 315 per pill or around Rs 10000 for a full month treatment.
What are the major Applications, Types and Regions for Global Growth Hormone Market?
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
Short-Acting Growth Hormones
Long-Acting Growth Hormones
By Application, it is segmented into
Growth Hormone Deficiency
Idiopathic Short Stature
Turner Syndrome
Small For Gestational Age
Prader-Willi Syndrome
Others
Global Growth Hormone Market Regional Analysis
Asia Pacific is projected to register a significant CAGR over the forecast period. Key players focus on gaining a major market share in potential countries of the Asia Pacific such as Japan and China by gaining approval and the launch of novel products. For instance, in March 2017, Novo Nordisk A/S, a Denmark-based pharmaceutical company, initiated the phase III clinical trial of its HGH somapacitan, indicated for the treatment of adult growth hormone deficiency, in Japan.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Global Growth Hormone Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Growth Hormone Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Global Growth Hormone Market scope?
Report Attributes
Report Details
Forecast Period 2022 to 2028 CAGR
CAGR of 7.6% during the review period (2022 to 2027).
By Types
Short-Acting Growth Hormones
Long-Acting Growth Hormones
By Application
Growth Hormone Deficiency
Idiopathic Short Stature
Turner Syndrome
Small For Gestational Age
Prader-Willi Syndrome
Others
By Companies
Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Number of Pages
117
Customization Available
Yes, the report can be customized as per your needs
Growth Drive –
GH deficiency was the largest application segment in 2019 owing to an increase in regulatory approvals and the launch of novel therapies
Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital pharmacy distribution channel segment
North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
Frequently Asked Question
What is the study period of this market?
The Global Growth Hormone Market is studied from 2022-2027.
Who are the prime players in the Global Growth Hormone Market?
Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc
Which region held the largest share in the Global Growth Hormone Market?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant Types of Global Growth Hormone Market?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.